Delivery Order SPE2DB24D2100-SPE2DB24FBCGC

Award Date 7/2/24
Potential Completion Date 7/24/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract worth $134,929.44 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $9,370.10 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VARIVAX vaccine with diluents. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
The Defense Logistics Agency (DLA) awarded a $1,874.02 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $3,748.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide VARIVAX vaccines with diluents. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $47,798.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a $26,767.16 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $149,921.60 to Amerisourcebergen Drug Corp's Corporate Office Division to provide VARIVAX vaccine with diluents. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $4,685.05 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
The Defense Logistics Agency (DLA) awarded a $9,370.10 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The Defense Logistics Agency (DLA) awarded a $50,598.54 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCGC
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division worth $5,622.06 to provide VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. As a subsidiary of one of the largest pharmaceutical distribution companies globally, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government medical product requirements.

Generated 10/1/24, 12:57 PM